D-
allose, a type of rare
sugar, can produce inhibitory effects on activated leukocytes in various organs, including immunosuppressive effects and anti-inflammatory effects, as well as anti-oxyradical effects. The present experiment was performed to investigate the potential anti-inflammatory effects of D-
allose in acute
cerebral ischemia/reperfusion (I/R) injury. Transient
middle cerebral artery occlusion model was applied in rats. D-
allose was administered two times via a tail vein (300 mg/kg, 1 hour before
ischemia and 10 hours after reperfusion). After 22 hours of reperfusion following 2 hours of
ischemia, brain damage was evaluated by
cerebral infarct volume.
Myeloperoxidase (MPO) activity assay by
enzyme-linked
immunosorbent assay, and
protein expression of MPO and
cyclooxygenase-2 (COX-2) by immunohistochemistry were evaluated to investigate the potential mechanisms of D-
allose. The experimental results showed that D-
allose exhibited significant
neuroprotective effects against acute cerebral I/R injury. The
infarct volume in D-
allose-treated rats (90.9 ± 13.5 mm(3)) was significantly smaller than that in vehicle rats (114.9 ± 15.3 mm(3), p < 0.01). D-
allose treatment significantly suppressed the MPO activity and the number of MPO-positive cells compared with those in the vehicle group, suggesting that treatment with D-
allose can reduce the infiltration of leukocytes into the ischemic tissue. Treatment of D-
allose also significantly decreased the number of COX-2-positive cells and microglial activation in the ischemic tissue. The present results demonstrate that D-
allose exerts potent
neuroprotective effects against acute cerebral I/R injury, and constitute the first evidence of anti-inflammatory effects of D-
allose which considerably contributes to the beneficial effects. Treatment with D-
allose might provide a new strategy and clinically beneficial outcome for
acute ischemic stroke.